- Home
- OVID vs CATO Comparison
OVID vs CATO Comparison
Compare OVID & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVID
- CATO
- Stock Information
- Founded
- OVID 2014
- CATO 1946
- Country
- OVID United States
- CATO United States
- Employees
- OVID N/A
- CATO N/A
- Industry
- OVID Biotechnology: Pharmaceutical Preparations
- CATO Clothing/Shoe/Accessory Stores
- Sector
- OVID Health Care
- CATO Consumer Discretionary
- Exchange
- OVID Nasdaq
- CATO Nasdaq
- Market Cap
- OVID 73.1M
- CATO 70.0M
- IPO Year
- OVID 2017
- CATO N/A
- Fundamental
- Price
- OVID $1.02
- CATO $3.77
- Analyst Decision
- OVID Strong Buy
- CATO
- Analyst Count
- OVID 5
- CATO 0
- Target Price
- OVID $4.04
- CATO N/A
- AVG Volume (30 Days)
- OVID 210.4K
- CATO 326.3K
- Earning Date
- OVID 11-12-2024
- CATO 11-21-2024
- Dividend Yield
- OVID N/A
- CATO 17.94%
- EPS Growth
- OVID N/A
- CATO N/A
- EPS
- OVID N/A
- CATO N/A
- Revenue
- OVID $631,695.00
- CATO $666,779,000.00
- Revenue This Year
- OVID $71.38
- CATO N/A
- Revenue Next Year
- OVID $5,144.81
- CATO N/A
- P/E Ratio
- OVID N/A
- CATO N/A
- Revenue Growth
- OVID 113.21
- CATO N/A
- 52 Week Low
- OVID $0.68
- CATO $3.02
- 52 Week High
- OVID $4.10
- CATO $7.80
- Technical
- Relative Strength Index (RSI)
- OVID 44.47
- CATO 43.16
- Support Level
- OVID $1.00
- CATO $3.29
- Resistance Level
- OVID $1.09
- CATO $4.26
- Average True Range (ATR)
- OVID 0.08
- CATO 0.27
- MACD
- OVID -0.00
- CATO 0.12
- Stochastic Oscillator
- OVID 27.27
- CATO 59.50
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.